These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19597130)

  • 21. Tenecteplase for stroke salvage therapy--extending the therapeutic window via CT based selection.
    Kamran S; Muzammil SM; Kamal AK
    J Pak Med Assoc; 2013 Mar; 63(3):406-7. PubMed ID: 23914652
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Fitzpatrick AE; Noone I; O'Shea DD
    N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115491
    [No Abstract]   [Full Text] [Related]  

  • 23. Alteplase for ischaemic stroke.
    Burrage D
    Lancet; 2014 Oct; 384(9953):1502. PubMed ID: 25390573
    [No Abstract]   [Full Text] [Related]  

  • 24. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.
    Dowlatshahi D; Hakim A; Fang J; Sharma M;
    Int J Stroke; 2009 Oct; 4(5):328-34. PubMed ID: 19765119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 26. Alteplase for ischaemic stroke--responses.
    Hudson I
    Lancet; 2014 Aug; 384(9944):662-3. PubMed ID: 25152268
    [No Abstract]   [Full Text] [Related]  

  • 27. Alteplase for ischaemic stroke--responses.
    Wardlaw JM; Murray V; Berge E; Del Zoppo GJ
    Lancet; 2014 Aug; 384(9944):661-2. PubMed ID: 25152267
    [No Abstract]   [Full Text] [Related]  

  • 28. Tissue plasminogen activator (tPA) for ischemic stroke in patients aged ≥80 years.
    Zhou C; Zhu L; Wu J; Fang S
    Acta Neurol Scand; 2013 Sep; 128(3):e17-8. PubMed ID: 23947769
    [No Abstract]   [Full Text] [Related]  

  • 29. Journey during acute ischemic stroke: a physician's experience.
    Hoong LC; Sharma VK
    Ann Fam Med; 2010; 8(3):265-7. PubMed ID: 20458112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenecteplase versus alteplase for acute ischemic stroke.
    González RG
    N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969
    [No Abstract]   [Full Text] [Related]  

  • 31. [The intervention treatment of neuroprotection for ischemic stroke].
    Wang YL; Liang H; Song SL
    Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):279-82. PubMed ID: 23189623
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of MR CLEAN.
    Donnan GA
    Int J Stroke; 2015 Feb; 10(2):139. PubMed ID: 25598023
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thrombolytic treatment in everyday clinical practice--efficacious and safe?].
    Grond M
    Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S129-31. PubMed ID: 17089257
    [No Abstract]   [Full Text] [Related]  

  • 34. MRI-assisted thrombolysis for delayed arrival among patients with ischemic stroke.
    Khatri R; Miley JT; Qureshi AI
    J Neuroimaging; 2011 Oct; 21(4):307-8. PubMed ID: 21121999
    [No Abstract]   [Full Text] [Related]  

  • 35. Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
    Coutts SB; Hill MD
    Stroke; 2015 Jun; 46(6):e150. PubMed ID: 25899240
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombolytics for hyperacute stroke in children.
    Amlie-Lefond C; Fullerton HJ
    Pediatr Hematol Oncol; 2009; 26(3):103-7. PubMed ID: 19382031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused.
    Davis SM; Hand PJ; Donnan GA
    Med J Aust; 2007 Nov; 187(10):548-9. PubMed ID: 18021039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expectations for tPA is pathway to litigation.
    ED Manag; 2011 Feb; 23(2):18-9. PubMed ID: 21400969
    [No Abstract]   [Full Text] [Related]  

  • 39. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Bruno A; Switzer JA
    Neurology; 2012 Jul; 79(5):486-7; author reply 486-7. PubMed ID: 22851721
    [No Abstract]   [Full Text] [Related]  

  • 40. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Kent TA
    Neurology; 2012 Apr; 78(17):1368. PubMed ID: 22529207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.